|
WO2006107826A2
(en)
|
2005-04-04 |
2006-10-12 |
The Board Of Regents Of The University Of Texas System |
Micro-rna's that regulate muscle cells
|
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
|
JP2008541737A
(ja)
*
|
2005-06-03 |
2008-11-27 |
サウザーン アデレード ヘルス サービス−ファインダーズ メディカル センター |
マイクロｒｎａ発現の変化した細胞を標的とすること
|
|
EP2434017A3
(en)
|
2006-08-01 |
2012-09-05 |
Board of Regents of the University of Texas System |
Identification of a micro-RNA that activates expression of beta-myosin heavy chain
|
|
WO2008071959A1
(en)
*
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
WO2008103755A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Mayo Foundation For Medical Education And Research |
Treating cancer with viral nucleic acid
|
|
WO2009018492A2
(en)
|
2007-07-31 |
2009-02-05 |
The Board Of Regents Of The University Of Texas System |
Micro-rnas that control myosin expression and myofiber identity
|
|
ES2621161T3
(es)
|
2007-07-31 |
2017-07-03 |
The Board Of Regents Of The University Of Texas System |
Familia de micro-ARN que modula la fibrosis y usos de la misma
|
|
CA2705325C
(en)
|
2007-11-09 |
2016-11-01 |
The Board Of Regents Of The University Of Texas System |
Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
|
|
CA2718520C
(en)
|
2008-03-17 |
2020-01-07 |
The Board Of Regents Of The University Of Texas System |
Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
|
|
US20110098346A1
(en)
*
|
2008-05-19 |
2011-04-28 |
Agency For Science, Technology And Research |
Nucleic acid molecule and method of targeting gene expression to gliomas
|
|
US9217155B2
(en)
*
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
US9938540B2
(en)
|
2008-11-12 |
2018-04-10 |
Ospedale San Raffaele S.R.L. |
Gene vector for inducing transgene-specific immune tolerance
|
|
CN101787373B
(zh)
*
|
2009-01-23 |
2013-06-19 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
|
|
MX2011008190A
(es)
|
2009-02-04 |
2011-10-06 |
Univ Texas |
Direccionamiento dual de mir-208 y mir-499 en el tratamiento de trastornos cardiacos.
|
|
CA2758928A1
(en)
|
2009-04-29 |
2010-11-04 |
Academisch Medisch Centrum Bij De Universiteit Van Amsterdam |
Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
|
|
AU2010243276B2
(en)
*
|
2009-04-30 |
2016-09-15 |
Fondazione Telethon Ets |
Gene vector
|
|
EP2425001A4
(en)
|
2009-04-30 |
2012-11-14 |
Univ California |
ANTI-HIV COMBINATION VECTORS, TARGETING VECTORS AND METHOD OF USE
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
DE102009050308A1
(de)
|
2009-10-22 |
2011-05-05 |
Ludwig-Maximilians-Universität München |
RNA mit einer Kombination aus unmodifizierten und modifizierten Nucleotiden zur Proteinexpression
|
|
DK2459231T3
(en)
*
|
2009-07-31 |
2016-09-05 |
Ethris Gmbh |
RNA with a combination of unmodified and modified nucleotides for protein expression
|
|
US8518392B2
(en)
|
2009-08-14 |
2013-08-27 |
Regeneron Pharmaceuticals, Inc. |
Promoter-regulated differentiation-dependent self-deleting cassette
|
|
WO2011130749A2
(en)
|
2010-04-16 |
2011-10-20 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
|
|
WO2011133874A1
(en)
|
2010-04-23 |
2011-10-27 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
JP2013533847A
(ja)
|
2010-04-23 |
2013-08-29 |
ユニバーシティ オブ マサチューセッツ |
コレステロール関連障害のａａｖベースの治療
|
|
EP3514232A1
(en)
*
|
2010-04-23 |
2019-07-24 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
WO2012008302A1
(ja)
*
|
2010-07-12 |
2012-01-19 |
国立大学法人鳥取大学 |
ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
|
|
US9309534B2
(en)
|
2010-07-12 |
2016-04-12 |
Universidad Autonoma De Barcelona |
Gene therapy composition for use in diabetes treatment
|
|
EP2638159B1
(en)
*
|
2010-11-11 |
2019-04-24 |
University of Miami |
Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
|
|
US8642751B2
(en)
|
2010-12-15 |
2014-02-04 |
Miragen Therapeutics |
MicroRNA inhibitors comprising locked nucleotides
|
|
WO2012143401A1
(en)
|
2011-04-18 |
2012-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tissue-specific regulation of transgene expression
|
|
WO2012145624A2
(en)
|
2011-04-21 |
2012-10-26 |
University Of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
CA2844012C
(en)
*
|
2011-08-04 |
2021-03-16 |
Yeda Research And Development Co. Ltd. |
Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
|
HUE068728T2
(hu)
|
2011-08-05 |
2025-01-28 |
Regeneron Pharma |
Humanizált univerzális könnyûláncú egerek
|
|
US9481895B2
(en)
|
2011-09-23 |
2016-11-01 |
Ge Healthcare Dharmacon, Inc. |
Introduction of modular vector elements during production of a lentivirus
|
|
US9428749B2
(en)
|
2011-10-06 |
2016-08-30 |
The Board Of Regents, The University Of Texas System |
Control of whole body energy homeostasis by microRNA regulation
|
|
EP2584040A1
(en)
|
2011-10-17 |
2013-04-24 |
Pharmahungary 2000 Kft. |
Compounds for treatment of ischemic injury
|
|
DE18200782T1
(de)
*
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
WO2013152230A1
(en)
|
2012-04-04 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
|
JP6208228B2
(ja)
|
2012-06-21 |
2017-10-04 |
ミラゲン セラピューティクス， インコーポレイテッド |
ロックド核酸モチーフを含むオリゴヌクレオチドベースの阻害剤
|
|
CN103505743A
(zh)
*
|
2012-06-21 |
2014-01-15 |
北京命码生科科技有限公司 |
含功能性microRNA/siRNA的细胞微粒子及其应用
|
|
US9163235B2
(en)
|
2012-06-21 |
2015-10-20 |
MiRagen Therapeutics, Inc. |
Inhibitors of the miR-15 family of micro-RNAs
|
|
CA2892529C
(en)
|
2012-11-26 |
2023-04-25 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
HK1217215A1
(zh)
|
2013-01-17 |
2016-12-30 |
Modernatx, Inc. |
用於改变细胞表型的信号传感器多核苷酸
|
|
LT2956477T
(lt)
|
2013-02-15 |
2021-02-10 |
Bioverativ Therapeutics Inc. |
Optimizuotas faktoriaus viii genas
|
|
JP6588024B2
(ja)
|
2013-10-28 |
2019-10-09 |
ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション |
腫瘍溶解性ｈｓｖベクター
|
|
US20150147774A1
(en)
*
|
2013-11-22 |
2015-05-28 |
National University Of Singapore |
Expression construct for yeast and a method of using the construct
|
|
WO2015127128A2
(en)
|
2014-02-19 |
2015-08-27 |
University Of Massachusetts |
Recombinant aavs having useful transcytosis properties
|
|
DK3119797T3
(da)
|
2014-03-18 |
2021-03-15 |
Univ Massachusetts |
Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
|
|
US10975391B2
(en)
|
2014-04-25 |
2021-04-13 |
University Of Massachusetts |
Recombinant AAV vectors useful for reducing immunity against transgene products
|
|
EP3160478A4
(en)
|
2014-06-30 |
2018-05-16 |
Bioverativ Therapeutics Inc. |
Optimized factor ix gene
|
|
US10973931B2
(en)
|
2014-09-16 |
2021-04-13 |
Universitat Autònoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
RU2020140209A
(ru)
|
2014-10-21 |
2021-01-25 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
|
ES2824457T3
(es)
*
|
2014-12-05 |
2021-05-12 |
UNIV AUTòNOMA DE BARCELONA |
Vectores virales para el tratamiento de la diabetes
|
|
EP3247716A4
(en)
|
2015-01-20 |
2018-10-17 |
Miragen Therapeutics, Inc. |
Mir-92 inhibitors and uses thereof
|
|
EP3256170B1
(en)
|
2015-02-13 |
2020-09-23 |
University of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
WO2016172008A1
(en)
|
2015-04-24 |
2016-10-27 |
University Of Massachusetts |
Modified aav constructions and uses thereof
|
|
EP3319631A4
(en)
|
2015-07-08 |
2019-01-09 |
American Gene Technologies International Inc. |
HIV PREMUNICATION AND IMMUNOTHERAPY
|
|
CA3001003A1
(en)
|
2015-10-05 |
2017-04-13 |
Modernatx, Inc. |
Methods for therapeutic administration of messenger ribonucleic acid drugs
|
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
|
CA3011529A1
(en)
|
2016-01-15 |
2017-07-20 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta t-cells
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
EP4089166A1
(en)
|
2016-01-27 |
2022-11-16 |
Oncorus, Inc. |
Oncolytic viral vectors and uses thereof
|
|
PL3411478T3
(pl)
|
2016-02-01 |
2022-10-03 |
Bioverativ Therapeutics Inc. |
Geny zoptymalizowanego czynnika VIII
|
|
US10888613B2
(en)
|
2016-02-08 |
2021-01-12 |
American Gene Technologies International Inc. |
Method of producing cells resistant to HIV infection
|
|
CA3012344A1
(en)
|
2016-02-12 |
2017-08-17 |
University Of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
ES2911448T3
(es)
|
2016-03-09 |
2022-05-19 |
American Gene Tech Int Inc |
Vectores combinados y métodos para el tratamiento del cáncer
|
|
EP3377637B1
(en)
*
|
2016-04-08 |
2020-03-18 |
Krystal Biotech, LLC |
Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin
|
|
WO2017201342A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding jagged1 for the treatment of alagille syndrome
|
|
EP3468617A4
(en)
|
2016-06-08 |
2020-01-22 |
American Gene Technologies International Inc. |
INTEGRATED VIRAL ADMINISTRATION SYSTEM AND RELATED METHODS
|
|
EP3478321A4
(en)
|
2016-06-30 |
2020-04-22 |
Oncorus, Inc. |
Pseudotyped oncolytic viral delivery of therapeutic polypeptides
|
|
IL300730A
(en)
|
2016-07-08 |
2023-04-01 |
American Gene Tech Int Inc |
Pre-HIV vaccine and immunotherapy
|
|
GB201612214D0
(en)
|
2016-07-14 |
2016-08-31 |
Univ Oxford Innovation Ltd |
Method
|
|
JP7176756B2
(ja)
|
2016-07-21 |
2022-11-22 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
パーキンソン病を処置するためのウイルスベクター
|
|
CA3031670A1
(en)
*
|
2016-07-26 |
2018-02-01 |
Senti Biosciences, Inc. |
Spatiotemporal regulators
|
|
JP2018029521A
(ja)
*
|
2016-08-24 |
2018-03-01 |
国立研究開発法人農業・食品産業技術総合研究機構 |
ｍｉＲ３９８標的核酸配列を含む、遺伝子導入のためのウイルスベクター
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
AU2017341849B2
(en)
|
2016-10-13 |
2024-03-21 |
University Of Massachusetts |
AAV capsid designs
|
|
KR20190104051A
(ko)
|
2017-01-06 |
2019-09-05 |
스타빌리테크 바이오파마 리미티드 |
바이러스
|
|
CN107384868A
(zh)
*
|
2017-02-17 |
2017-11-24 |
中国农业科学院上海兽医研究所 |
永生化原代绵羊肺细胞系的构建及其应用
|
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
US11576872B2
(en)
|
2017-05-08 |
2023-02-14 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
CA3062591A1
(en)
*
|
2017-05-08 |
2018-11-15 |
Gritstone Oncology, Inc. |
Alphavirus neoantigen vectors
|
|
JP7327803B2
(ja)
|
2017-05-09 |
2023-08-16 |
ユニバーシティ オブ マサチューセッツ |
筋萎縮性側索硬化症（ａｌｓ）を処置する方法
|
|
AU2018265541B2
(en)
|
2017-05-12 |
2023-05-25 |
University Of Massachusetts |
Viral vector production
|
|
ES2871146T3
(es)
|
2017-07-14 |
2021-10-28 |
Immatics Biotechnologies Gmbh |
Molécula de polipéptido con especificidad dual mejorada
|
|
KR20200042904A
(ko)
*
|
2017-07-26 |
2020-04-24 |
온코루스, 인크. |
종양용해성 바이러스 벡터 및 그의 용도
|
|
IT201700086403A1
(it)
*
|
2017-07-27 |
2019-01-27 |
Univ Del Piemonte Orientale |
Endothelial-specific promoter sequences and uses thereof
|
|
JP7374883B2
(ja)
|
2017-08-09 |
2023-11-07 |
バイオベラティブ セラピューティクス インコーポレイテッド |
核酸分子およびその使用
|
|
EP3444347A1
(en)
|
2017-08-18 |
2019-02-20 |
Universität Heidelberg |
Use of anti-crispr polypeptides for specific activation of cas nucleases
|
|
CN111448321A
(zh)
|
2017-09-22 |
2020-07-24 |
马萨诸塞大学 |
Sod1双表达载体及其用途
|
|
CN111433356B
(zh)
|
2017-10-10 |
2023-12-19 |
南特生物科学公司 |
对病毒生产有效载荷具有低毒性的经修饰的ec7细胞
|
|
CN111727259B
(zh)
|
2017-12-01 |
2024-04-19 |
编码治疗公司 |
工程化的dna结合蛋白
|
|
BR112020009532A2
(pt)
*
|
2017-12-15 |
2020-11-03 |
Medizinische Hochschule Hannover |
composto melhorado para tratamento de insuficiência cardíaca
|
|
EP3731850A4
(en)
|
2017-12-29 |
2021-12-01 |
Oncorus, Inc. |
ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
|
|
JP7653013B2
(ja)
|
2018-01-04 |
2025-03-28 |
アイコニック セラピューティクス リミテッド ライアビリティ カンパニー |
抗組織因子抗体、抗体薬物コンジュゲート、及び関連する方法
|
|
WO2019152692A1
(en)
|
2018-02-01 |
2019-08-08 |
Bioverativ Therapeutics, Inc. |
Use of lentiviral vectors expressing factor viii
|
|
US10716866B2
(en)
|
2018-03-29 |
2020-07-21 |
Generoath Co., Ltd |
Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof
|
|
US20210228627A1
(en)
|
2018-05-15 |
2021-07-29 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
CA3105953A1
(en)
|
2018-07-09 |
2020-01-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
CN119955796A
(zh)
|
2018-08-09 |
2025-05-09 |
比奥维拉迪维治疗股份有限公司 |
核酸分子及其用于非病毒基因疗法的用途
|
|
AU2019333315B2
(en)
|
2018-08-30 |
2022-09-29 |
Tenaya Therapeutics, Inc. |
Cardiac cell reprogramming with myocardin and ASCL1
|
|
SG11202103151RA
(en)
|
2018-09-28 |
2021-04-29 |
Voyager Therapeutics Inc |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
US20210381001A1
(en)
*
|
2018-10-11 |
2021-12-09 |
Eidgenössische Technische Hochschule Zürich |
A method to treat disease using a nucleic acid vector encoding a highly compact multi-input logic gate
|
|
WO2020097049A1
(en)
|
2018-11-05 |
2020-05-14 |
American Gene Technologies International Inc. |
Vector system for expressing regulatory rna
|
|
CA3120282A1
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
US20230043255A1
(en)
|
2018-11-14 |
2023-02-09 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|
|
EP3880179A2
(en)
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for cns delivery
|
|
WO2020117713A1
(en)
*
|
2018-12-03 |
2020-06-11 |
California Institute Of Technology |
In situ readout of dna barcodes
|
|
BR112021010047A2
(pt)
|
2018-12-06 |
2021-08-24 |
Bioverativ Therapeutics Inc. |
Uso de vetores lentivirais expressando o fator ix
|
|
JOP20210160A1
(ar)
*
|
2018-12-21 |
2023-01-30 |
Univ Pennsylvania |
تركيبات لخفض التعبير عن الجين الناقل بشكل انتقائي لـ drg
|
|
JP2022516318A
(ja)
*
|
2019-01-04 |
2022-02-25 |
オンコラス， インコーポレイテッド |
カプセル化ポリヌクレオチド及び使用方法
|
|
KR102248420B1
(ko)
*
|
2019-03-15 |
2021-05-06 |
주식회사 제너로스 |
miR-142-3p의 표적 서열을 포함하는 재조합 벡터
|
|
US20220202960A1
(en)
*
|
2019-04-24 |
2022-06-30 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of rett syndrome
|
|
MX2021014525A
(es)
*
|
2019-05-30 |
2022-03-17 |
Gritstone Bio Inc |
Adenovirus modificados.
|
|
CN114521143B
(zh)
|
2019-09-19 |
2025-03-14 |
吉尼松公司 |
减轻fkrp心脏毒性的基因治疗表达系统
|
|
CN115279896A
(zh)
|
2019-09-30 |
2022-11-01 |
比奥维拉迪维治疗股份有限公司 |
慢病毒载体配制品
|
|
KR102461417B1
(ko)
*
|
2019-11-11 |
2022-11-01 |
주식회사 온코크로스 |
아데노바이러스 벡터를 포함하는 전립선암 진단용 조성물
|
|
US20230210883A1
(en)
*
|
2020-03-13 |
2023-07-06 |
Duke University |
Compositions for the treatment of nash and associated disorders and methods of using same
|
|
MX2022012059A
(es)
*
|
2020-03-30 |
2023-02-14 |
Greffex Inc |
Aumento de la produccion de vectores de genetransferencia a base de adenovirus.
|
|
IL297635A
(en)
*
|
2020-04-27 |
2022-12-01 |
Univ Pennsylvania |
Compositions useful in treatment of cdkl5 deficiency disorder (cdd)
|
|
AU2021270447A1
(en)
*
|
2020-05-12 |
2023-01-05 |
The Trustees Of The University Of Pennsylvania |
Compositions for DRG-specific reduction of transgene expression
|
|
WO2021255245A2
(en)
|
2020-06-19 |
2021-12-23 |
Genethon |
Gene therapy expression system allowing an adequate expression in the muscles and in the heart of sgcg
|
|
MX2023000156A
(es)
|
2020-06-24 |
2023-02-16 |
Bioverativ Therapeutics Inc |
Metodos para la eliminacion de factor viii libre de preparaciones de vectores lentivirales modificados para expresar dicha proteina.
|
|
US20230277686A1
(en)
|
2020-07-10 |
2023-09-07 |
Genethon |
A novel muscle-specific promoter
|
|
CA3187258A1
(en)
|
2020-08-06 |
2022-02-10 |
Karin Jooss |
Multiepitope vaccine cassettes
|
|
CA3189673A1
(en)
|
2020-08-23 |
2022-03-03 |
Ajay MAGHODIA |
Modified baculovirus system for improved production of closed-ended dna (cedna)
|
|
KR102626543B1
(ko)
*
|
2020-09-14 |
2024-01-23 |
주식회사 제너로스 |
AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터
|
|
KR20220035693A
(ko)
*
|
2020-09-14 |
2022-03-22 |
주식회사 제너로스 |
표적화된 유전자 전달을 위한 아데노-부속 바이러스 벡터
|
|
JP7121086B2
(ja)
*
|
2020-09-25 |
2022-08-17 |
ウニベルシダッド アウトノマ デ バルセロナ |
脂肪組織に形質導入するのに有用なアデノ随伴ウイルスベクター
|
|
WO2022070142A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Generoath Co., Ltd. |
METHODS OF TREATING AGE-RELATED MACULAR DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF
|
|
BR112023022765A2
(pt)
|
2021-05-05 |
2024-01-02 |
Immatics Biotechnologies Gmbh |
Proteínas de ligação ao antígeno que ligam especificamente o prame
|
|
AU2022271727A1
(en)
*
|
2021-05-13 |
2023-12-14 |
Akouos, Inc. |
Gene therapy delivery compositions and methods for treating hearing loss
|
|
AU2022334711A1
(en)
|
2021-08-23 |
2024-04-04 |
Bioverativ Therapeutics Inc. |
Baculovirus expression system
|
|
EP4392443A1
(en)
|
2021-08-23 |
2024-07-03 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
CA3232988A1
(en)
|
2021-09-30 |
2023-04-06 |
Bioverativ Therapeutics Inc. |
Nucleic acids encoding factor viii polypeptides with reduced immunogenicity
|
|
WO2023142040A1
(en)
*
|
2022-01-29 |
2023-08-03 |
Virogin Biotech Canada Ltd. |
Transcriptional and translational dual regulated oncolytic herpes simplex virus vectors
|
|
CN119343154A
(zh)
*
|
2022-05-13 |
2025-01-21 |
杰内罗蒂股份有限公司 |
使用AIMP2-DX2和任选的miR-142靶序列及其组合物治疗视网膜退行性疾病的方法
|
|
WO2025024559A1
(en)
|
2023-07-24 |
2025-01-30 |
Strand Therapeutics Inc. |
Rna-based synthetic circuit for producing engineered immune cells for an extracorporeal cell therapy
|
|
US12281311B1
(en)
*
|
2024-02-20 |
2025-04-22 |
Wyvern Pharmaceuticals Inc. |
Composition for regulating production of interfering ribonucleic acid
|